Regulatory
-
Apr 18 2014
GSK Pharma net profit falls 43% on price control
It is being seen as an unprecedented decline in the…
Read more -
FDA bans Indian firms from producing drugs for the U.S.
FDA bans Indian firms from producing drugs for the U.S.…
Read more -
Drug regulator lets pharma firms fix own penalty Resource crunch is coming in the way of the drug regulator’s attempt to prevent over-pricing of medicines
Pharmaceutical companies could enjoy a leeway while pricing their products,…
Read more -
1.5-2 million beds by 2025 from the current 1-1.25 million
A lion’s share (almost 80 percent) of this growth will…
Read more -
The Reserve Bank (RBI) has sought clarity on whether foreign portfolio investments can be allowed in existing companies without government approval
NEW DELHI: The Reserve Bank (RBI) has sought clarity on…
Read more -
Sun Pharma Asked to Halt Clinical Research in Mumbai
The Drug Controller General of India has ordered Sun Pharmaceutical,…
Read more -
-
SC asks why govt approved 162 global clinical trials in India Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process
The apex court on Monday directed the health ministry to…
Read more -
India ruling deals blow to German pharma giant
An Indian company can sell a generic version of Bayer…
Read more -
Managing constant pharmaceutical sales: Kick-starting prescriptions
Managing constant pharmaceutical sales: Kick-starting prescriptions A cursory glance at…
Read more